Lorviqua Uniunea Europeană - română - EMA (European Medicines Agency)

lorviqua

pfizer europe ma eeig - lorlatinib - carcinom, pulmonar non-celulă mică - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

LORVIQUA 100 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorviqua 100 mg

pfizer manufacturing deutschland gmbh - germania - lorlatinibum - compr. film. - 100mg - inhibitori de protein-kinaza

LORVIQUA 25 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorviqua 25 mg

pfizer manufacturing deutschland gmbh - germania - lorlatinibum - compr. film. - 25mg - inhibitori de protein-kinaza

Orserdu Uniunea Europeană - română - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - sânii neoplasme - terapia endocrină - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

ERLOTINIB RATIOPHARM 100 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

erlotinib ratiopharm 100 mg

pliva hrvatska d.o.o. (pliva croatia ltd.) - polonia - erlotinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza

ERLOTINIB RATIOPHARM 150 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

erlotinib ratiopharm 150 mg

pliva hrvatska d.o.o. (pliva croatia ltd.) - polonia - erlotinibum - compr. film. - 150mg - alte antineoplazice inhibitori de protein-kinaza

ERLOTINIB RATIOPHARM 25 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

erlotinib ratiopharm 25 mg

pliva hrvatska d.o.o. (pliva croatia ltd.) - polonia - erlotinibum - compr. film. - 25mg - alte antineoplazice inhibitori de protein-kinaza

LAPATINIB STADA 250 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lapatinib stada 250 mg

remedica ltd. - cipru - lapatinibum - compr. film. - 250mg - inhibitori de protein-kinaza

ERLOTINIB TEVA 25 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

erlotinib teva 25 mg

pliva croatia ltd. - croatia - erlotinibum - compr. film. - 25mg - alte antineoplazice inhibitori de protein-kinaza

ERLOTINIB TEVA 100 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

erlotinib teva 100 mg

pliva croatia ltd. - croatia - erlotinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza